Profil bibliographique

Sven C. van Dijkman

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

29Publications signalées

426Citations signalées

0Affiliations récentes

Domaines associés

Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesAsthma and respiratory diseasesAntibiotics Pharmacokinetics and EfficacyChronic Obstructive Pulmonary Disease (COPD) Research

Publications récentes

Accès ouvert 2026 articleOpenAlex

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

Sven C. van Dijkman, Mathieu Felices, Bhaskar Pandurangavittal, Sanman Ghorpade et autres

1 citationBritish Journal of Clinical Pharmacology

Accès ouvert 2025 articleOpenAlex

Evaluation of the Effect of Clobetasol Propionate on Circulating Cortisol and Growth Velocity in Children with Atopic Dermatitis: A Modelling and Simulation Study

Janna K. Duong, Sven C. van Dijkman, G B Ong, Alexandra Marta et autres

1 citationDermatology

Accès ouvert 2025 articleOpenAlex

Cefuroxime axetil dosing regimens and probability of target attainment in adults and children

Sven C. van Dijkman, Pravin Kamble, J KOWALSKI, Oscar Della Pasqua

2 citationsBritish Journal of Clinical Pharmacology

Accès ouvert 2025 articleOpenAlex

Characterizing local and systemic exposure to clobetasol propionate in healthy subjects and patients with atopic dermatitis

Janna K. Duong, Sven C. van Dijkman, G B Ong, Alexandra Marta et autres

8 citationsBritish Journal of Clinical Pharmacology

Accès ouvert 2025 articleOpenAlex

Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit

Leticia Arrington, Sven C. van Dijkman, Elodie L. Plan, Mats O. Karlsson

0 citationsCPT Pharmacometrics & Systems Pharmacology

2024 conference-abstractOpenAlex

Treatable traits and personalised management of moderate-severe asthma: implications for reliever use, symptom control and exacerbation risk

Gabriel García, Dave Singh, Ian Pavord, Sven C. van Dijkman et autres

0 citations

Accès ouvert 2024 articleOpenAlex

Study APV20002: Safety and Efficacy Results Through Week 684 for Pediatric Participants Living with HIV-1 Treated with Ritonavir-Boosted Fosamprenavir Oral Solution–Based Antiretroviral Therapy

Lisa Ross, Mark F. Cotton, Has Cassim, H Garges et autres

0 citationsAIDS Research and Human Retroviruses

Accès ouvert 2024 articleOpenAlex

Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1

Hardik Chandasana, Sven C. van Dijkman, Rashmi Mehta, Mark Bush et autres

3 citationsInfectious Diseases and Therapy

Accès ouvert 2024 articleOpenAlex

A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate–Severe Asthma

Gabriel García, Sven C. van Dijkman, Ian Pavord, Dave Singh et autres

5 citationsAdvances in Therapy

Accès ouvert 2024 articleOpenAlex

Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials

Sven C. van Dijkman, Arzu Yorgancıoğlu, Ian Pavord, Guy Brusselle et autres

6 citationsAdvances in Therapy

2022 articleOpenAlex

MODELING OF SHORT-ACTING BETA AGONIST (SABA) USE: EFFECT OF SYMPTOM CONTROL IN PATIENTS WITH MODERATE-SEVERE ASTHMA REQUIRING RESCUE MEDICATION

PAULO PITREZ, GUY G BRUSSELLE, ARZU YORGANCIOĞLU, Ian Pavord et autres

0 citationsCHEST Journal

Accès ouvert 2022 articleOpenAlex

Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications

Lindsey Ingleby-Talecki, Sven C. van Dijkman, Sean P. Oosterholt, Oscar Della Pasqua et autres

30 citationsClinical and Translational Science

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.